Este primer tramo ha contado con la participación de USM Global Corporation, un vehículo de inversión que agrupa a varios inversores de crowdfunding de Capital Cell, ENISA, 4M Medical GmbH -el dist...
Flomics Biotech, a biotech company dedicated to genomics and early screening and diagnosis of complex diseases, such as cancer, announces the closing of a €1.000.000 seed round of investment, led by...
The round was led by RA Capital Management and Andera Partners. Additional new investors included RTW Investments, Rock Springs Capital, SR One Capital Management, Sectoral Asset Management, Ysios Cap...
Cara Care announced a $7M equity financing round today led by family-owned international food and nutrition manufacturer Dr. Schär AG, alongside existing investors Sabadell Asabys and Johnson & Johns...
La startup donostiarra Glucovibes ha cerrado una ronda de financiación de medio millón de euros liderada por inversores privados. Con la inyección de capital, la empresa ha superado el millar de cl...
Dialogue with investors is no easy task for entrepreneurs in the healthcare sector. We will focus more on how to negotiate a round in the health Venture Capital investor sector in this article, and...
Libera Bio has announced that it has closed its Seed Round to advance its MPN Technology® into enabling studies and towards the clinic. Investors include Xesgalicia, Semola Tech Ventures, ROSP Co...
AtG Therapeutics is a recently created spin-off from IDIBELL and ICO, announces its launch with a first round of financing collecting 556,000 euros, received the support of international and national ...
The final closing of the Seed round consistsof € 1M investmentby i&i Biotech Fund I (i&i Bio), an early-stage Life Science fund with teams in Luxemburg and Prague which is backed by the European Inv...
El Biohub, el nuevo edificio de La Marina de València, acogerá el próximo 20 de octubre VLC Health&I Day, una iniciativa liderada por Innosalud, Bioval e Innotransfer, como representantes del clús...
Innerva Pharmaceuticals, compañía que desarrolla un nuevo fármaco para el tratamiento del dolor ocular asociado al ojo seco y a otras enfermedades de la superficie ocular, ha completado una ronda d...
En la operación han participado Decelera Ventures I FCR como lead investor (tras la participación de Exheus en el programa Decelera Menorca, organizado en la isla balear) junto a WA4STEAM, NEXT GEN ...